Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Alaunos Therapeutics Inc TCRT

Healthcare Biotechnology
Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. The Company is focused on exploring strategic alternatives, including, but not limited to, an acquisition, merger, reverse merger, sale of assets, strategic partnerships, capital raises or other transactions. Separately, the Company is evaluating several potential in-licensing opportunities in obesity... see more

Recent & Breaking News (NDAQ:TCRT)

Alaunos Therapeutics to Present at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference

GlobeNewswire August 24, 2022

Alaunos Therapeutics Reports Second Quarter 2022 Financial Results

GlobeNewswire August 15, 2022

Alaunos Therapeutics to Report Second Quarter 2022 Financial Results on August 15, 2022

GlobeNewswire August 8, 2022

Alaunos Therapeutics Appoints Abhishek Srivastava, Ph.D. as Vice President, Technical Operations

GlobeNewswire August 4, 2022

Thinking about buying stock in Verrica Pharmaceuticals, Scisparc, Adverum Biotechnologies, OneConnect Financial Tech, or Alaunos Therapeutics?

PR Newswire July 6, 2022

Alaunos Therapeutics and the National Cancer Institute Extend Cooperative Research and Development Agreement for Development of Personalized TCR-T Cell Therapies to 2025

GlobeNewswire June 27, 2022

Alaunos Therapeutics to Present at the Jefferies Healthcare Conference

GlobeNewswire June 1, 2022

Alaunos Therapeutics to Present Trials in Progress Poster for its TCR-T Library Phase 1/2 trial at the 2022 American Society of Clinical Oncology Annual Meeting

GlobeNewswire May 26, 2022

Alaunos Therapeutics Reports First Quarter 2022 Financial Results

GlobeNewswire May 16, 2022

Alaunos Therapeutics to Present at the H.C. Wainwright Global Investment Conference

GlobeNewswire May 10, 2022

Alaunos Therapeutics to Report First Quarter 2022 Financial Results on May 16, 2022

GlobeNewswire May 9, 2022

Alaunos Therapeutics to Present at American Society of Gene and Cell Therapy 25th Annual Meeting

GlobeNewswire May 2, 2022

Alaunos Therapeutics Doses First Patient in TCR-T Library Phase 1/2 trial for the Treatment of Patients with Solid Tumors

GlobeNewswire May 2, 2022

Alaunos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire March 30, 2022

Alaunos Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on March 30, 2022

GlobeNewswire March 16, 2022

Alaunos Therapeutics to Participate in the Oppenheimer 32nd Annual Healthcare Conference

GlobeNewswire March 8, 2022

Ziopharm Oncology Highlights Operational Progress & Rebrands to Alaunos Therapeutics

GlobeNewswire January 26, 2022

Ziopharm Oncology Presents Preclinical Data Supporting TCR-T Library Approach at the Society for Immunotherapy of Cancer 2021 Annual Meeting

GlobeNewswire November 9, 2021

Ziopharm Oncology Reports Third Quarter 2021 Financial Results and Provides Business Update

GlobeNewswire November 8, 2021

Ziopharm Oncology to Report Third Quarter Financial Results on November 8, 2021

GlobeNewswire November 1, 2021